Navigation Links
Tumor in Bone Shows Neanderthals Got Cancer Too
Date:6/6/2013

THURSDAY, June 6 (HealthDay News) -- Cancer is often lamented as a modern-day scourge, but researchers have discovered a type of bone cancer in a 120,000-year-old Neanderthal rib.

Before this discovery was made in Krapina, Croatia, the earliest evidence of this type of bone tumor, known as fibrous dysplasia, dated back 1,000 to 4,000 years.

The researchers, who reported the finding online June 5 in the journal PLoS One, said the specimen found is incomplete so they can't determine the effects the tumor had on the Neanderthal's overall health.

"Evidence for cancer is extremely rare in the human fossil record," David Frayer, of the University of Kansas, said in a journal news release. "This case shows that Neanderthals, living in an unpolluted environment, were susceptible to the same kind of cancer as living humans."

The average lifespan of Neanderthals was likely about half that of humans in developed countries today, and they were exposed to a different environment, the researchers said.

"Given these factors, cases of neoplastic disease are rare in prehistoric human populations," the researchers said. "Against this background, the identification of a more than 120,000-year-old Neanderthal rib with a bone tumor is surprising, and provides insights into the nature and history of the association of humans to neoplastic disease."

Fibrous dysplasia is more common today than other bone tumors, Frayer said.

More information

The American Academy of Orthopaedic Surgeons provides more information on fibrous dysplasia.

-- Mary Elizabeth Dallas

SOURCE: Public Library of Science, news release, June 5, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Improved Stem Cell Line May Avoid Tumor Risk: Study
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. Dental X-Rays May Be Linked to Benign Brain Tumors
4. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
5. Brain Tumor Vaccine Shows Promise in Early Trial
6. Kidney Cancer Patients Fare Better With Tumor Removal Only
7. IBN discovers human neural stem cells with tumor targeting ability
8. Protein prevents DNA damage in the developing brain and might serve as a tumor suppressor
9. Small molecular bodyguards kill HPV-infected cancer cells by protecting tumor-suppressor
10. New surgical technique for removing inoperable tumors of the abdomen
11. Combination of 2 drugs reverses liver tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tumor in Bone Shows Neanderthals Got Cancer Too
(Date:4/26/2017)... ... , ... Journal of Oral Implantology – Tooth loss is not ... health, including complications with speech, eating, and overcompensation of mouth due to the deficiency. ... As the number of tooth replacements increase, it is imperative to design an implant ...
(Date:4/26/2017)... ... 2017 , ... Elisabete Miranda, president and CEO of ... magazine as one of its 2017 Enterprising Women of the Year, a prestigious ... that they have fast-growth businesses, mentor or actively support other women and girls ...
(Date:4/26/2017)... NJ (PRWEB) , ... April 26, 2017 , ... RawTrition ... an easy way to get nutrients from SUPERFOODS! , RawTrition is taking ... at the cellular level because the body recognizes its raw form (unlike the synthetically ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, ... to announce that it has received 510(k) clearance from the U.S. Food & ... the MyoCycle Pro. , Both devices are stationary cycling systems that use MYOLYN’s ...
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition Duchenne, ... Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics on ... clinical trial in Duchenne announced today. , Coalition Duchenne funded studies carried ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
Breaking Medicine Technology: